Antoni Salvà1, José Antonio Serra-Rexach2, Iñaki Artaza3, Francesc Formiga4, Xavier Rojano I Luque5, Federico Cuesta6, Alfonso López-Soto7, Ferran Masanés7, Domingo Ruiz8, Alfonso J Cruz-Jentoft9. 1. Fundació Salut i Envelliment, Universitat Autònoma de Barcelona, Barcelona, España; Institut de Recerca Biomèdica Sant Pau, Barcelona, España. Electronic address: antoni.salva@uab.cat. 2. Geriatría, Hospital General Universitario Gregorio Marañón, Madrid, España. 3. Igurco Servicios Sociosanitarios, Bilbao, España. 4. Medicina Interna, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, España. 5. Fundació Salut i Envelliment, Universitat Autònoma de Barcelona, Barcelona, España; Institut de Recerca Biomèdica Sant Pau, Barcelona, España. 6. Geriatría, Hospital Clínico San Carlos, Madrid, España; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España. 7. Medicina Interna, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, España; Facultat de Medicina, Universitat de Barcelona, Barcelona, España. 8. Institut de Recerca Biomèdica Sant Pau, Barcelona, España; Geriatría, Hospital de Sant Pau, Barcelona, España; Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, España. 9. Geriatría, Hospital Universitario Ramón y Cajal, Madrid, España.
Abstract
INTRODUCTION: The main aim of this study is to assess the prevalence of sarcopenia, according to the criteria of the European Working Group on Sarcopenia in Older People, in men and women living in Spanish nursing homes. METHODS: Multi-centre study was conducted on ambulatory persons over 69 years old living in nursing homes. Body composition was assessed using bioimpedance analysis, grip strength with a Jamar dynamometer, and gait speed using the 4 metre walk test. Sarcopenia was assessed using the European Working Group on Sarcopenia in Older People criteria (gait speed<0.8m/s; grip strength<30kg in men or 20kg in women, and muscle mass index <8.31kg/m(2) in men or<6.68kg/m(2) in women). RESULTS: The study included 276 subjects with a median age 87.2 years, and with 69% women. Sarcopenia was demonstrated in 37% (15% men, 46% women), 37% had low muscle mass, 86% low gait speed, and 95% low grip strength. Prevalence of sarcopenia increased with advancing age. Both weakness and low gait speed was observed in 90% of individuals with sarcopenia, with 39% of the total having low gait speed, and 38% with weakness. CONCLUSION: Sarcopenia is a frequent condition in older persons living in nursing homes, especially among women. Most of the cases are severe, with both low muscle strength and physical performance. Although muscle function is altered in 9 out 10 participants, most of them have preserved muscle mass.
INTRODUCTION: The main aim of this study is to assess the prevalence of sarcopenia, according to the criteria of the European Working Group on Sarcopenia in Older People, in men and women living in Spanish nursing homes. METHODS: Multi-centre study was conducted on ambulatory persons over 69 years old living in nursing homes. Body composition was assessed using bioimpedance analysis, grip strength with a Jamar dynamometer, and gait speed using the 4 metre walk test. Sarcopenia was assessed using the European Working Group on Sarcopenia in Older People criteria (gait speed<0.8m/s; grip strength<30kg in men or 20kg in women, and muscle mass index <8.31kg/m(2) in men or<6.68kg/m(2) in women). RESULTS: The study included 276 subjects with a median age 87.2 years, and with 69% women. Sarcopenia was demonstrated in 37% (15% men, 46% women), 37% had low muscle mass, 86% low gait speed, and 95% low grip strength. Prevalence of sarcopenia increased with advancing age. Both weakness and low gait speed was observed in 90% of individuals with sarcopenia, with 39% of the total having low gait speed, and 38% with weakness. CONCLUSION:Sarcopenia is a frequent condition in older persons living in nursing homes, especially among women. Most of the cases are severe, with both low muscle strength and physical performance. Although muscle function is altered in 9 out 10 participants, most of them have preserved muscle mass.
Authors: F Masanés; X Rojano I Luque; A Salvà; J A Serra-Rexach; I Artaza; F Formiga; F Cuesta; A López Soto; D Ruiz; A J Cruz-Jentoft Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Jacobo Á Rubio-Arias; Raquel Rodríguez-Fernández; Luis Andreu; Luis M Martínez-Aranda; Alejandro Martínez-Rodriguez; Domingo J Ramos-Campo Journal: J Clin Med Date: 2019-12-06 Impact factor: 4.241
Authors: Carlos Guillamón-Escudero; Angela Diago-Galmés; David Zuazua Rico; Alba Maestro-González; Jose M Tenías-Burillo; Jose M Soriano; Julio J Fernández-Garrido Journal: Int J Environ Res Public Health Date: 2022-07-11 Impact factor: 4.614
Authors: F Buckinx; J Y Reginster; T Brunois; C Lenaerts; C Beaudart; J L Croisier; J Petermans; O Bruyère Journal: J Musculoskelet Neuronal Interact Date: 2017-09-01 Impact factor: 2.041
Authors: Laura Muñoz-Bermejo; Santos Villafaina; Daniel Collado-Mateo; Salvador Postigo-Mota; José Carmelo Adsuar Journal: Medicina (Kaunas) Date: 2019-10-16 Impact factor: 2.430
Authors: Fredy Alonso Patiño-Villada; Jerónimo J González-Bernal; Josefa González-Santos; José Antonio de Paz; Maha Jahouh; Juan Mielgo-Ayuso; Ena Monserrat Romero-Pérez; Raúl Soto-Cámara Journal: Int J Environ Res Public Health Date: 2020-10-23 Impact factor: 3.390